You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCG

Showing 26 - 50 of 589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-specific Effects of BCG in Under-five Children

Active, not recruiting
  • Immunity, Heterologous
  • BCG
  • Lisboa, Portugal
    Instituto de Higiene e Medicina Tropical
Jul 20, 2022

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

Not yet recruiting
  • Non-Muscle Invasive Bladder Cancer
  • HER2
  • (no location specified)
Jul 16, 2023

High-risk NMIBC Trial (SHR-1501)

Recruiting
  • High-risk NMIBC
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 28, 2022

Mild Cognitive Impairment, Healthy Trial in Charlestown (Bacillus Calmette-Guerin (BCG))

Active, not recruiting
  • Mild Cognitive Impairment
  • Healthy
  • Bacillus Calmette-Guerin (BCG)
  • Charlestown, Massachusetts
    Clinical Translational Research Unit
Jul 18, 2022

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Covid19, Morbidity, Absenteeism Trial in Bissau, Manhiça (BCG-Denmark, Saline)

Completed
  • Covid19
  • +2 more
  • BCG-Denmark
  • Saline
  • Bissau, SAB, Guinea-Bissau
  • +1 more
Nov 2, 2022

Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

Not yet recruiting
  • Bladder Cancer
  • +5 more
  • Bacillus Calmette-Guerin: Strain Russian BCG-I
  • Bacillus Calmette-Guerin: Strain TICE
  • (no location specified)
Apr 7, 2022

Bladder Cancer Trial in Nara, Okayama (FE 999326)

Recruiting
  • Bladder Cancer
  • FE 999326
  • Nara, Japan
  • +1 more
Jan 19, 2023

Covid19, Non-specific Effects of Vaccines, Heterologous Immunity Trial in Odense (BCG-Denmark, Saline)

Active, not recruiting
  • Covid19
  • +5 more
  • BCG-Denmark
  • Saline
  • Odense, Denmark
    Seniorhuset
Feb 28, 2022

Fibromyalgia Trial in Charlestown (Bacillus Calmette Guerin Vaccine, Saline Injection)

Withdrawn
  • Fibromyalgia
  • Bacillus Calmette Guerin Vaccine
  • Saline Injection
  • Charlestown, Massachusetts
    Immunobiology Labs CNY 149
Apr 5, 2022

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Tuberculosis Trial in Shenzhen (BCG-PPD)

Recruiting
  • Tuberculosis
  • Shenzhen, Guangdong, China
    The Third People's Hospital Of Shenzhen
Jun 27, 2022

Infant Mortality, BCG Trial in Bissau (BCG-Denmark 1331 (Statens Serum Institute))

Terminated
  • Infant Mortality
  • BCG
  • BCG-Denmark 1331 (Statens Serum Institute)
  • Bissau, Guinea-Bissau
    Bandim Health Project
Feb 3, 2022

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

Superficial Bladder Cancer Trial in United States (EG-70)

Recruiting
  • Superficial Bladder Cancer
  • Tucson, Arizona
  • +7 more
May 11, 2022

COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)

Active, not recruiting
  • COVID-19
  • +4 more
  • BCG
  • Placebo
  • Campinas, SP, Brazil
    Hospital das Clínicas Unicamp
Mar 23, 2022

Non-Muscle Invasive Bladder Cancer Trial in Mansoura (Bacillus Calmette-Guerin)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Bacillus Calmette-Guerin
  • Mansoura, Outside U.S./Canada, Egypt
    Urology and Nephrology Center
Apr 11, 2022

Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)

Recruiting
  • Voiding Disorders
  • Mirabegron, Propevirine, Solifenacin
  • Mansoura, Egypt
    Urology and Nephrology Center, Mansoura University
Aug 3, 2022

Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)

Recruiting
  • Invasive Bladder Cancer
  • Madrid, Spain
    Hospital 12 de Octubre
Feb 8, 2022

Intravesical BCG: is the Urinary Bladder Ready to Receive it

Not yet recruiting
  • Non-Invasive Bladder Urothelial Carcinoma
    • (no location specified)
    Jun 7, 2022

    Tuberculosis Trial in Worcester (MTBVAC, BCG)

    Completed
    • Tuberculosis
    • MTBVAC
    • BCG
    • Worcester, Western Cape, South Africa
      SATVI: Worcester
    Aug 26, 2022

    Tuberculosis Infection, Tuberculosis Trial (BCG vaccine, Oral Chemoprophylaxis)

    Not yet recruiting
    • Tuberculosis Infection
    • Tuberculosis
    • BCG vaccine
    • Oral Chemoprophylaxis
    • (no location specified)
    Jul 4, 2022

    Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

    Recruiting
    • Bladder Urothelial Carcinoma In Situ
    • +5 more
    • Acupuncture Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 27, 2022

    Diabetes, Type 1, Diabetes type1, Autoimmune Diabetes Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)

    Recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • Bacillus Calmette-Guérin
    • Saline Injection
    • Charlestown, Massachusetts
      Immunobiology Labs CNY 149
    Mar 22, 2022